These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 7913948)

  • 1. Evidence for a primary involvement of somatostatin in clonidine-induced growth hormone release in conscious rats.
    Lanzi R; Lapointe M; Gurd W; Tannenbaum GS
    J Endocrinol; 1994 May; 141(2):259-66. PubMed ID: 7913948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonidine potentiates the growth hormone response to a growth hormone releasing hormone challenge in hypothalamic growth hormone releasing hormone deficient rats.
    Arce V; García Barros M; Vara E; Lima L; Tresguerres JA; Devesa J
    Neuroendocrinology; 1995 May; 61(5):552-8. PubMed ID: 7617133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fetal ethanol exposure on the in vitro release of growth hormone, somatostatin and growth hormone-releasing factor induced by clonidine and growth hormone feedback in male and female rats.
    Conway S; Ling SY; Leidy JW; Blaine K; Holtzman T
    Alcohol Clin Exp Res; 1997 Aug; 21(5):826-39. PubMed ID: 9267532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonidine potentiates the growth hormone (GH) response to GH-releasing hormone in norepinephrine synthesis-inhibited rats: evidence for an alpha-2-adrenergic control of hypothalamic release of somatostatin.
    Lima L; Arce V; Tresguerres JA; Devesa J
    Neuroendocrinology; 1993 Jun; 57(6):1155-60. PubMed ID: 7901787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent reduction and potentiation of growth hormone (GH) responsiveness to GH-releasing factor induced by exogenous GH: role for somatostatin.
    Lanzi R; Tannenbaum GS
    Endocrinology; 1992 Apr; 130(4):1822-8. PubMed ID: 1347739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroidectomy abolishes pulsatile growth hormone secretion without affecting hypothalamic somatostatin.
    Martin D; Epelbaum J; Bluet-Pajot MT; Prelot M; Kordon C; Durand D
    Neuroendocrinology; 1985 Dec; 41(6):476-81. PubMed ID: 2867482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
    Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M
    Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonidine pretreatment modifies the growth hormone secretory pattern induced by short-term continuous GRF infusion in normal man.
    Lima L; Arce V; Diaz MJ; Tresguerres JA; Devesa J
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):129-35. PubMed ID: 1934527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of impaired growth hormone secretion in genetically obese Zucker rats: roles of growth hormone-releasing factor and somatostatin.
    Tannenbaum GS; Lapointe M; Gurd W; Finkelstein JA
    Endocrinology; 1990 Dec; 127(6):3087-95. PubMed ID: 1979030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone (GH) secretion in the dwarf rat: release, clearance and responsiveness to GH-releasing factor and somatostatin.
    Carmignac DF; Robinson IC
    J Endocrinol; 1990 Oct; 127(1):69-75. PubMed ID: 1983310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone (GH)-releasing factor stimulates hypothalamic somatostatin release: an inhibitory feedback effect on GH secretion.
    Katakami H; Arimura A; Frohman LA
    Endocrinology; 1986 May; 118(5):1872-7. PubMed ID: 3084210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intravenous or intracerebroventricular injections of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on GH release in conscious, freely moving male rats.
    Yagi H; Kaji H; Sato M; Okimura Y; Chihara K
    Neuroendocrinology; 1996 Feb; 63(2):198-206. PubMed ID: 9053785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of growth hormone-releasing factor (GRF) activity in the pituitary and hypothalamus of the conscious rat with a peptidic GRF antagonist.
    Lumpkin MD; McDonald JK
    Endocrinology; 1989 Mar; 124(3):1522-31. PubMed ID: 2537185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of glucocorticoid treatment and acute passive immunization with growth hormone-releasing hormone and somatostatin antibodies on endogenous and stimulated growth hormone secretion in the male rat.
    Miell J; Corder R; Miell PJ; McClean C; Gaillard RC
    J Endocrinol; 1991 Oct; 131(1):75-86. PubMed ID: 1683888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo studies with growth hormone (GH)-releasing factor and clonidine in rat pups: ontogenetic development of their effect on GH release and synthesis.
    Cella SG; Locatelli V; De Gennaro V; Pellini C; Pintor C; Müller EE
    Endocrinology; 1986 Sep; 119(3):1164-70. PubMed ID: 3089765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexual dimorphism of somatostatin and growth hormone-releasing factor signaling in the control of pulsatile growth hormone secretion in the rat.
    Painson JC; Tannenbaum GS
    Endocrinology; 1991 Jun; 128(6):2858-66. PubMed ID: 1674685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intracellular glucopenia on pulsatile growth hormone secretion: mediation in part by somatostatin.
    Painson JC; Tannenbaum GS
    Endocrinology; 1985 Sep; 117(3):1132-8. PubMed ID: 2862015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenergic and cholinergic involvement in basal and growth hormone-releasing hormone-stimulated growth hormone secretion in glucocorticoid-treated rats.
    Giustina A; Misitano V; Voltz D; Piering A; Wehrenberg WB
    Endocr Res; 1995 Nov; 21(4):719-32. PubMed ID: 8582323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
    Devesa J; Diaz MJ; Tresguerres JA; Arce V; Lima L
    J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of insulin-like growth factor I in regulating growth hormone release and feedback in the male rat.
    Becker K; Stegenga S; Conway S
    Neuroendocrinology; 1995 May; 61(5):573-83. PubMed ID: 7617136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.